KCM
SGMO

Kennedy Capital Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Kennedy Capital Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-60,008
Closed -$502K – 721
2019
Q4 		$502K Sell
60,008
-62,172
-51% -$572K 0.01% 656
2019
Q3 		$1.11M Buy
+122,180
New +$1.37M 0.03% 586
2015
Q1 		– Sell
-103,585
Closed -$1.58M – 754
2014
Q4 		$1.58M Buy
103,585
+7,405
+8% +$89.9K 0.03% 601
2014
Q3 		$1.04M Buy
96,180
+46,552
+94% +$608K 0.02% 658
2014
Q2 		$758K Buy
+49,628
New +$714K 0.01% 670

Other funds holding SGMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Kennedy Capital Management's SGMO Position: Q1 2020 in Review

Kennedy Capital Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q1 2020, closing a stake of 60,008 shares — an estimated $502K sold.

Kennedy Capital Management first reported a position in SGMO in Q2 2014 and held it in 5 quarters. The position peaked at $1.58M in Q4 2014. 190 funds tracked by Wall St. Rank hold SGMO as of Q1 2020.

  • Kennedy Capital Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q1 2020 after selling out during the quarter.
  • Kennedy Capital Management sold 60,008 SANGAMO THERAPEUTICS INC shares in Q1 2020, an estimated $502K.
  • Kennedy Capital Management first reported a position in SANGAMO THERAPEUTICS INC in Q2 2014 and held it in 5 quarters.
  • Kennedy Capital Management's SANGAMO THERAPEUTICS INC position peaked at $1.58M in Q4 2014.
  • 190 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2020.

Based on Kennedy Capital Management's 13F filing for Q1 2020, filed 15 May 2020.